Sector-Specific Global Patent Tactics: Tech, Pharma, and Manufacturing There is no “one-size-fits-all” international patent strategy for commercial companies. What works for a software or AI firm may be ineffective—or even harmful—for a pharmaceutical innovator or an industrial manufacturer. Each sector differs in R&D cycle length, product lifespan, regulatory intensity, imitation patterns, and commercialization models, so […]